Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

6.54
Delayed Data
As of Mar 27
 -0.48 / -6.84%
Today’s Change
3.71
Today|||52-Week Range
14.80
+43.42%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line-1.6M-3.3M-4.2M-5.7M
 
 
 
 
 
Depreciation28.3K14.7K5.4K6.0K
 
 
 
 
 
Total Other Cash Flow-76.9K768.5K1.2M1.5M
 
 
 
 
 
Funds From Operations-1.6M-2.6M-3.0M-4.2M
 
 
 
 
 
Funds From/For Other Operating Expenses56.2K-259.7K353.3K-161.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-1.7M-2.3M-3.4M-4.1M
 
 
 
 
 
 
InvestingIncrease In Investments-1.7M-475.4K-5.8M-55.8M
 
 
 
 
 
Decrease In Investments0.002.3M1.3M42.7M
 
 
 
 
Capital Expenditures-2.2K-2.1K-6.4K-14.0K
 
 
 
 
 
Other Investing - Uses-14.3K-3.6K-2.1K-2.0K
 
 
 
 
 
Other Investing - Sources2.4K0.004.9K2.0K
 
 
 
 
Net Cash Flow Investing-1.7M1.8M-4.6M-13.1M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale3.7M3.5M5.8M16.6M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing3.7M3.5M5.8M16.6M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash---38.9K-18.1K6.0K
 
 
 
 
 
Net Change In Cash313.7K3.0M-2.1M-516.0K
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account